Does HRT Prevent Osteoporosis? What Evidence Shows

Bone loss is the menopause symptom you cannot feel. There is no equivalent of a hot flush to tell you it is happening, and for most women the first sign is a fracture that should not have happened, from a fall that should not have mattered. By then a good deal of the loss is already behind you.

The short answer: yes. Estrogen is approved for the prevention of postmenopausal osteoporosis, and it is one of a small number of treatments shown in a large randomised trial to reduce fractures in women who were not selected for having low bone density in the first place. That is a genuinely strong result. The important caveat is that the protection depends on continuing: bone loss resumes once you stop.

Why menopause is the turning point

Bone is living tissue that rebuilds itself continuously. Cells called osteoclasts break old bone down, osteoblasts lay new bone in its place, and for most of your life the two stay roughly in balance.

Estrogen is one of the main brakes on the breakdown side. When it falls at menopause, the brake comes off. Resorption speeds up, formation does not keep pace, and the balance tips into net loss. The rate is fastest in the years immediately around the final period, which is why this window matters so much: up to a fifth of the bone a woman will lose in her lifetime can come off in the first five to seven years after menopause.

What the evidence actually shows

The Women's Health Initiative is best known for its findings on breast cancer and cardiovascular risk, which were widely reported and widely misunderstood. Less discussed is that the same trial produced unusually clear positive evidence on bone.

In the combined estrogen and progestogen arm, hip fractures, vertebral fractures and total fractures were all reduced. What makes this result stand out is the population: these were ordinary postmenopausal women, not women recruited because they already had osteoporosis. Most fracture prevention evidence comes from trials that deliberately enrol high risk women, which makes it much harder to know what a treatment does for everyone else. Here we know.

The catch: it is not permanent

Protection lasts as long as treatment does. Once estrogen stops, bone turnover picks up again and loss resumes, in some studies fairly quickly. Hormone therapy is not a course you complete; it is an ongoing intervention while you take it.

This is worth understanding before you start, because it shapes how you think about stopping later. It is not a reason to avoid treatment. It is a reason to have a plan for what happens if and when you come off.

Is bone protection a reason to take HRT on its own?

Here the answer becomes more nuanced, and it is worth being straight about that rather than overselling.

For a woman in her early fifties who has hot flushes, disturbed sleep and joint aches, and who also wants to protect her bones, hormone therapy is an excellent fit. It treats what is bothering her and protects her skeleton at the same time. The bone benefit is a strong supporting argument.

For a woman of 68 with no symptoms and established osteoporosis, the calculation is different. Starting hormone therapy well past menopause carries a different risk profile, and there are drugs designed specifically for osteoporosis that would usually be considered first. Hormone therapy is not generally recommended as a first line osteoporosis treatment for older women with no menopausal symptoms.

The exception that matters most: early menopause

If you went through menopause early, before 45, or you have premature ovarian insufficiency, the guidance is different and much more emphatic. Hormone therapy is recommended at least until the average age of natural menopause, around 51, and bone protection is a central reason. You are facing far more years of estrogen deficiency than someone who reached menopause on schedule, and the bone consequences accumulate accordingly. Our guide to premature menopause and POI covers this in detail.

What else actually moves the needle

Hormone therapy is not a substitute for the rest, and the rest is not a substitute for hormone therapy. They work on different parts of the problem.

Loading your skeleton

Bone responds to being stressed. Resistance training and impact are the forms that matter, and swimming and cycling, however good for you otherwise, do not load bone in the same way. Lifting something heavy enough to be difficult, two or three times a week, is the intervention with the best evidence.

Protein, calcium and vitamin D

Bone is roughly half protein by volume, and low protein intake is common in midlife women. Calcium and vitamin D are the raw materials and the absorption mechanism respectively. None of these builds bone on their own, but a deficiency in any of them undermines everything else. Our piece on how much protein you actually need in menopause covers the numbers.

Not falling over in the first place

Most fractures need two ingredients: a weakened bone and a fall. Bone treatment addresses one of them, and balance work addresses the other, yet only one of the two usually gets discussed.

Single leg stands while the kettle boils, and any activity that challenges balance under control, both reduce fall risk measurably. So does reviewing medications that cause dizziness, and having your eyesight checked. None of it is glamorous and all of it compounds.

Knowing your starting point

You cannot manage what you have not measured. A DEXA scan gives you a baseline, and the baseline is worth as much as the number, because it lets any future scan show a direction rather than a snapshot. The standard advice to wait until 65 is too late for a lot of women, and we set out when to ask for one earlier separately.

What happens if you stop, and what else is available

Because the protection is not permanent, the sensible question is what the plan looks like afterwards, and it is one worth asking at the start rather than at the end.

For a woman who stops hormone therapy in her early sixties with reasonable bone density and no other risk factors, the answer is often that nothing further is needed beyond loading the skeleton, eating enough protein, and rechecking density at a sensible interval. Bone loss resumes but from a better starting point than it would have been.

For a woman who already has osteoporosis, or who has other significant risk factors, the conversation shifts to whether a bone-specific treatment should take over. Bisphosphonates are the usual first line, and there are other options including denosumab and, for higher risk, anabolic agents that build bone rather than merely slowing its loss. None of these treats hot flushes, which is the trade-off if hormone therapy was doing both jobs.

Risk assessment tools

Clinicians often use a fracture risk calculator, most commonly FRAX, which combines your age, weight, height, fracture history, family history, smoking, steroid use and alcohol intake, with or without a bone density result, to estimate your ten-year probability of a major fracture. It is a useful way of turning a scan result into a decision, and it is worth asking whether yours has been calculated rather than just filed.

The reason it matters is that bone density alone is an incomplete picture. A woman with mildly reduced density and several other risk factors may face a higher fracture risk than a woman with worse numbers and none of them.

Talking to a provider about it

Bone rarely comes up in a short appointment because it is not what is bothering you today. If it matters to you, raise it deliberately. Ask whether your risk factors justify a DEXA now rather than at 65, whether hormone therapy is appropriate for you given your symptoms and history, and what the plan would be if you later stop.

Our questions to ask any HRT provider includes bone among them, and our directory lists clinicians who work in menopause specifically. If there is nobody local, telehealth menopause services cover most states.

The bottom line

Hormone therapy genuinely protects bone, with better evidence than most people realise, and the protection lasts as long as the treatment does. If you have menopausal symptoms and you also want to protect your skeleton, that is a strong combination of reasons. If your only concern is bone and you are well past menopause, it is worth discussing the alternatives too.

For current guidance see the Bone Health and Osteoporosis Foundation and The Menopause Society.